To learn more, please call our Research Department at (513) 936-5388 or (888) 649-4800. Or email abradley@ohcmail.com
- OVARIAN III-IV, FIRST LINE
- Study number:
- GYN 19 SCRI IIT
- Protocol title:
- A Randomized Phase II Study of Paclitaxel/Carboplatin With and without Sorafenib on the First-Line treatment of Patients with Stage III/IV Epithelial Ovarian Cancer
- Status:
- Open
-
| Endometrial- early stage/high risk |
| Study Number: |
GOG-0249 |
| Protocol title: |
A Phase III Trial of Pelvic Radiation Therapy versus
Vaginal Cuff Brachytherapy followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High Risk, Early Stage Endometrial Cancer |
| Status: |
Open
|
ADVANCED SECOND LINE RECURRENT OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL
Study number:
GYN 26 SCRI
-
- Protocol title:
- A Phase I/II Study of the Combination of Pazopanib and Liposomal doxorubicin (Doxil) in Patients with Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma
- Status:
- Open